How a Common Chemo Drug Eats Away at Muscle, and a Possible Way to Block It
Cisplatin is a widely used cancer drug, but it often wastes away muscle. In mice, scientists found that an immune signaling pathway called cGAS-STING drives much of this muscle loss. Switching off this pathway in muscle helped protect it from the drug's damage. This points to a possible target for keeping muscle intact during chemo.
Disclaimer: Research summaries are provided for informational purposes only and do not constitute medical advice. Always consult a qualified healthcare professional before making changes to your health routine.
Related Studies
All researchHow Exercise Quiets a Muscle-Wasting Inflammation Signal in Older Women
Scientists found a specific inflammation signal called CXCL2 that climbs as muscle loss gets worse with age.
NMN Protected Rat Testes From Chemotherapy Damage in Early Study
The chemo drug doxorubicin badly damages the testes, a real worry for male cancer patients.
A Single Protein's Decline in Immune Cells May Drive Body-Wide Aging
In mice, a protein called Lamtor5 drops with age and lets immune cells called macrophages go into a worn-out, inflammatory state.